Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,748.00    -12.00 (-0.32%)
Bid:
3,748.00
Ask:
3,752.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Directorate Change

18 Oct 2024 07:00

RNS Number : 6755I
4imprint Group PLC
18 October 2024
 

 

 18 October 2024

 

4imprint Group plc

 

CFO Designate Appointment

 

 

4imprint Group plc ("4imprint" or the "Company") today announces the appointment of Michelle Brukwicki as CFO Designate effective 9 December 2024. This follows the announcement on 22 May 2024 that David Seekings had informed the Company of his intention to retire from the Board and from his role as CFO before the end of 2025. David's six month notice period will commence from December 31st. 

 

The appointment follows a thorough and rigorous recruitment and selection process led by the Nomination Committee of the Board. 

 

Michelle is a Certified Public Accountant in the US with accounting experience gained initially with Deloitte & Touche and is presently Senior Vice President - Finance and Chief Financial Officer of TDS Telecom, a division of Telephone and Data Systems, Inc (TDS). Michelle brings over 25 years of financial and accounting related experience at publicly listed companies, along with extensive experience in strategic planning and business development, leadership development, enterprise risk management and investor relations. 

 

Michelle will initially be appointed as CFO Designate and then is expected to become CFO and be appointed to the Board no later than May 31, 2025. A further announcement will be made in due course. 

 

Paul Moody, Chair, commented: "Michelle brings a wealth of relevant technical experience to the company, as well as proven evidence of strategic thought. As importantly, Michelle's approach to the leadership and development of people, together with her personal values make her a perfect fit with our company's culture. I am looking forward to working with Michelle."

 

Kevin Lyons-Tarr, CEO, commented: "I am delighted to welcome Michelle to 4imprint. Her extensive experience, leadership style and strategic mindset will undoubtedly be an invaluable addition to our team as we work together to drive the business forward."

 

Michelle Brukwicki, CFO Designate, commented: "It is an honour to join 4imprint as the next CFO. The Company's purpose, operations and culture are very impressive. I look forward to collaborating with the Board, the management team, and associates across the organization to build on 4imprint's strong foundation."

 

 

Notes: 

1. There is no further information in respect of Michelle Brukwicki which would require disclosure under Listing Rule 6.4.6. 

2. Michelle Brukwicki's remuneration arrangements have been set in accordance with the Directors' Remuneration Policy approved by shareholders, including an annual salary of $470,000pa, an entitlement to an annual bonus opportunity of up to 150% and an invitation to join the new 4imprint LTIP starting in 2025.

 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

Email: hq@4imprint.co.uk

MHP Group

Tel. + 44 (0) 7884 494112

Email: 4imprint@mhpgroup.com

 

Kevin Lyons-Tarr

Chief Executive Officer

 

Emma Taylor

Company Secretary

Katie Hunt

 

 

Eleni Menikou

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRBDGBGBDGSR
Date   Source Headline
2nd Apr 20203:34 pmRNSDirector/PDMR Shareholding
1st Apr 202012:03 pmRNSPrice Monitoring Extension
30th Mar 202011:02 amRNSAnnual Financial Report
30th Mar 20208:32 amRNSHolding(s) in Company
26th Mar 202011:43 amRNSHolding(s) in Company
24th Mar 20203:09 pmRNSHolding(s) in Company
24th Mar 202012:02 pmRNSPrice Monitoring Extension
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSCOVID-19 Update
13th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20204:25 pmRNSHolding(s) in Company
5th Mar 20208:49 amRNSHolding(s) in Company
3rd Mar 20202:38 pmRNSHolding(s) in Company
3rd Mar 20207:00 amRNSFinal Results
26th Feb 20203:55 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSTrading Update and Notice of Final Results
30th Dec 20197:00 amRNSDirectorate Change
23rd Dec 20192:53 pmRNSHolding(s) in Company
18th Dec 20192:46 pmRNSHolding(s) in Company
17th Dec 20193:01 pmRNSEBT Purchase
6th Nov 20198:30 amRNSHolding(s) in Company
5th Nov 20194:24 pmRNSEBT Purchase
4th Nov 20197:00 amRNSTrading Update
29th Oct 20199:01 amRNSEBT Purchase
25th Oct 20199:22 amRNSHolding(s) in Company
17th Oct 20193:51 pmRNSHolding(s) in Company
3rd Oct 20193:55 pmRNSHolding(s) in Company
3rd Oct 20191:14 pmRNSEBT Purchase
2nd Oct 20194:59 pmRNSHolding(s) in Company
30th Sep 201910:30 amRNSDirector/PDMR Shareholding
13th Sep 20194:38 pmRNSHolding(s) in Company
9th Sep 20199:11 amRNSEBT Purchase
27th Aug 20192:42 pmRNSDirector/PDMR Shareholding
14th Aug 20199:48 amRNSHolding(s) in Company
31st Jul 20197:00 amRNSHalf-year Report
29th Jul 20198:55 amRNSHolding(s) in Company
12th Jul 20194:28 pmRNSHolding(s) in Company
1st Jul 201910:03 amRNSDirector/PDMR Shareholding
25th Jun 20199:11 amRNSHolding(s) in Company
14th Jun 20199:25 amRNSEBT Purchase
20th May 201911:18 amRNSEBT purchase
7th May 20192:21 pmRNSResult of AGM
7th May 20197:00 amRNSAGM Statement
24th Apr 201911:56 amRNSEBT Purchase
4th Apr 201911:21 amRNSHolding(s) in Company
4th Apr 201911:09 amRNSDirector/PDMR Shareholding
3rd Apr 20198:29 amRNSHolding(s) in Company
1st Apr 20193:57 pmRNSAnnual Financial Report
28th Mar 20193:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.